Evidence map›Paper›PMID 40886287›Full record

ReviewAdvances in experimental medicine and biology2025

Circular RNAs in Respiratory Diseases.

Sema Misir, Serap Ozer Yaman, Ceylan Hepokur, Yuksel Aliyazicioglu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sema MisirDepartment of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas, Turkey. smisir@cumhuriyet.edu.tr.
Serap Ozer YamanDepartment of Medical Biochemistry, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
Ceylan HepokurDepartment of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas, Turkey.
Yuksel AliyaziciogluDepartment of Medical Biochemistry, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory diseases are among the most severe diseases and are among the leading causes of death in the world. Early diagnosis and prognosis prediction, as well as effective treatment, are vital to reducing mortality rates. Recently, increasing reports have shown that circRNAs are associated with the occurrence and progression of cancerous and noncancerous respiratory diseases through different mechanisms. In this chapter, we summarize the critical roles of circRNAs in the occurrence and progression of respiratory diseases. We also discussed the opportunity to use these molecules as potential therapeutic targets for diagnosing, prognosing, and treating respiratory diseases.

Indexed as

Respiratory Tract DiseasesRNA, CircularAnimalsBiomarkersHumansPrognosisBiomarkersRNA, CircularBiomarkerCircular RNAMicroRNA spongeRespiratory diseases

Identifiers

PMID40886287

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.